KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Weighted Average) (2016 - 2025)

Pacira BioSciences has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $44.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $44.6 million for Q4 2025, down 3.63% from a year ago — trailing twelve months through Dec 2025 was $44.6 million (down 3.63% YoY), and the annual figure for FY2025 was $44.6 million, down 3.63%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $44.6 million at Pacira BioSciences, down from $45.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for PCRX hit a ceiling of $46.5 million in Q1 2024 and a floor of $43.8 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $45.8 million (2022), compared with a mean of $45.5 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 4.91% in 2021 and later fell 3.63% in 2025.
  • Pacira BioSciences' Shares Outstanding (Weighted Average) stood at $44.3 million in 2021, then grew by 2.84% to $45.5 million in 2022, then grew by 1.54% to $46.2 million in 2023, then grew by 0.05% to $46.2 million in 2024, then fell by 3.63% to $44.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $44.6 million (Q4 2025), $45.3 million (Q3 2025), and $45.9 million (Q2 2025) per Business Quant data.